Joint gas-phase electron diffraction and quantum chemical study of conformational landscape and molecular structure of sulfonamide drug sulfanilamide

被引:1
作者
Inna N. Kolesnikova
Anatolii N. Rykov
Vladimir V. Kuznetsov
Igor F. Shishkov
机构
[1] Lomonosov Moscow State University,Chemistry Department
[2] Russian Academy of Sciences,N. D. Zelinsky Institute of Organic Chemistry
来源
Structural Chemistry | 2020年 / 31卷
关键词
Sulfanilamide; Molecular structure; Conformational composition; Conformational isomerism; Inversion; Gas-phase electron diffraction; Quantum chemistry; Substituent effect;
D O I
暂无
中图分类号
学科分类号
摘要
Conformational composition and molecular structure of sulfanilamide (para-aminobenzenesulfonamide, SA) has been investigated by means of gas electron diffraction (GED) and quantum chemical (QC) calculations. Conformations with eclipsed orientation of the S=O and the N–H bonds in the sulfonamide moiety have been found to be predominant in vapor at the average temperature of the GED experiment of 184(5) °C. The structural parameters of the most stable conformer are the following (rh1 in Å and ∠h1 in ° with 3σ in parenthesis): r(C=C) av = 1.410(4), r(S=O)av = 1.433(4), r(C–S) = 1.763(6), r(S–N) = 1.649(6), ∠CSN = 104.7(15), (∠CSO)av = 109.0(8). The orientation of the S–N bond of the sulfonamide group about the anilinic ring plane has been found to be different from orthogonal by about 13°. It has been shown that QC calculations tend to overestimate the values the S=O bond lengths as well as are not always accurate in the prediction of mutual orientation of the sulfonamide group and the anilinic ring plane. While in the gas phase, low energy conformations are found to be the most abundant; the molecular structure of SA in the crystal phase resembles a high energy conformation with staggered orientation of the N–H and the S=O bonds for all polymorph modifications. The mechanisms of mutual transformations of different SA conformers into each other have also been considered and discussed.
引用
收藏
页码:1353 / 1362
页数:9
相关论文
共 158 条
[1]  
Domagk G(1935)Acta Cryst Dtsch Med Wochenschr 61 250-253
[2]  
Miert ASJPAMV(1994)Toma’s-Vert F J Vet Pharmacol Therap 17 309-316
[3]  
Woods DD(1962)undefined J Gen Microbiol 29 687-702
[4]  
Sköld O(2000)undefined Drug Resist Updat 3 155-160
[5]  
Achari A(1997)undefined Nat Struct Biol 4 490-497
[6]  
Somers DO(2014)undefined Future Med Chem 61 1149-1165
[7]  
Champness JN(2015)undefined J Med Chem 58 8564-8572
[8]  
Bryant PK(2016)undefined ACS Med Chem Lett 7 1028-1033
[9]  
Rosemond J(1965)undefined Acta Cryst 18 363-366
[10]  
Stammers DK(1965)undefined Acta Cryst 18 731-736